Condition 1: Pelvic pains. Condition 2: Anxiety and depression. Diseases of the genitourinary system Mixed anxiety and depressive disorder
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Being Iranian Declaration of consent to participate in the study Age range from 18 to 38 years Having any degree (one, two, or three) of primary dysmenorrhoea having regular menstrual cycles with intervals of 21 to 35 days and a duration of 3 to 10 days at least during the last six months Obtaining a score of 8 or higher on the HADS questionnaire Access to smartphones
Exclusion criteria
Exclusion criteria: History of genital diseases, surgery, and known and chronic underlying diseases Taking birth control pills Having hormonal disorders, irregular menstruation Pelvic infection, burning and itching, and abnormal vaginal discharge Professional sports activities Complaining about another pain in the hip area according to the student Current or history of severe mental illness such as severe depression, bipolar, suicidal thoughts Consumption of psychoactive substances or alcohol and drugs Having symptoms of depression or anxiety Taking anti-depressants and anxiety medications during the study Participation in other psychological interventions such as psychotherapy, meditation, yoga The occurrence of stressful events at least six months before the start of the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pelvic pains. Timepoint: on the second day of the first menstrual cycle before the study and three consecutive cycles after the intervention. Method of measurement: Short-Form McGill Pain Questionnaire.;Depression. Timepoint: on the second day of the first menstrual cycle before the study and three consecutive cycles after the intervention. Method of measurement: Hospital anxiety and depression questionnaire.;Anxiety. Timepoint: on the second day of the first menstrual cycle before the study and three consecutive cycles after the intervention. Method of measurement: Hospital anxiety and depression questionnaire. | — |
Secondary
| Measure | Time frame |
|---|---|
| Menstrual distress. Timepoint: On the second day of the first menstrual cycle before the study and three consecutive cycles after the intervention. Method of measurement: Moos Menstrual Distress Questionnaire.;Pain self-efficacy. Timepoint: On the second day of the first menstrual cycle before the study and three consecutive cycles after the intervention. Method of measurement: Pain Self-efficacy Questionnaire.;Perceived stress. Timepoint: On the second day of the first menstrual cycle before the study and three consecutive cycles after the intervention. Method of measurement: Perceived Stress Scale Questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Babol University of Medical Sciences